Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans

Background. The novel influenza vaccine MVA-NP+M1 is designed to boost cross-reactive T-cell responses to internal antigens of the influenza A virus that are conserved across all subtypes, providing protection against both influenza disease and virus shedding against all influenza A viruses. Followi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lillie, Patrick J., Berthoud, Tamara K., Powell, Timothy J., Lambe, Teresa, Mullarkey, Caitlin, Spencer, Alexandra J., Hamill, Matthew, Peng, Yanchun, Blais, Marie-Eve, Duncan, Christopher J. A., Sheehy, Susanne H., Havelock, Tom, Faust, Saul N., Williams, Rob Lambkin, Gilbert, Anthony, Oxford, John, Dong, Tao, Hill, Adrian V. S., Gilbert, Sarah C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369564/
https://www.ncbi.nlm.nih.gov/pubmed/22441650
http://dx.doi.org/10.1093/cid/cis327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369564/
https://www.ncbi.nlm.nih.gov/pubmed/22441650
http://dx.doi.org/10.1093/cid/cis327

Ejemplares similares